Workplace Cannabis Policies: A Moving Target
Employers face a patchwork of conflicting laws, unreliable drug tests, and no good way to measure impairment — but a practical framework for cannabis workplace policies is possible.
Quick Facts
What This Study Found
The legal landscape for workplace cannabis use is a mess. Federal law still classifies cannabis as Schedule I, but dozens of states have legalized medical or recreational use, leaving employers stranded between contradictory legal obligations. The authors map out exactly why most workplace drug policies are outdated and propose a practical framework.
The core problem with workplace drug testing for cannabis is that standard urine tests detect THC metabolites for days or weeks after use — long after any impairment has passed. A positive test tells you someone used cannabis at some point, not that they're impaired right now. This creates a disconnect that's becoming harder to defend legally, especially in states with employee protections for off-duty cannabis use.
The authors argue that workplace policies should be built around three factors: safety sensitivity of the job (an airline pilot vs. an office worker), whether the jurisdiction has legal protections for cannabis users, and whether the employer can actually measure impairment rather than just past use. For safety-sensitive positions, stricter testing is legally defensible. For most other jobs, the trend is moving toward impairment-based policies rather than zero-tolerance approaches.
They also note that different cannabis products (edibles vs. smoked flower vs. concentrates) produce dramatically different impairment profiles, and that current testing technology cannot distinguish between these delivery methods or accurately assess real-time impairment.
Key Numbers
As of the review date, 37 states had legalized medical cannabis and 18 had legalized recreational use. Standard urine tests can detect THC metabolites for up to 30 days in chronic users. The review found no validated, widely-accepted test for real-time cannabis impairment in workplace settings.
How They Did This
Narrative review of published literature from PubMed/NLM databases covering workplace cannabis policies, drug testing methods, legal frameworks, and impairment measurement. The authors synthesized findings from employment law, toxicology, and occupational health research to develop a practical policy framework.
Why This Research Matters
Most workplace cannabis policies were written when cannabis was illegal everywhere. Now that the majority of U.S. states have some form of legal cannabis, these policies create real problems: employers face lawsuits for firing employees who use cannabis legally off-duty, while workers in safety-sensitive jobs may be impaired on the clock with no reliable way to detect it. This review provides a rare practical roadmap for updating policies that actually match the current legal and scientific reality.
The Bigger Picture
This review connects directly to the broader drug testing challenge seen in RTHC-00081 (Swedish workplace testing over 25 years) and RTHC-00079 (oral fluid testing accuracy). Together, these studies paint a picture of workplace drug testing in transition — old methods don't match new laws, and the science of measuring actual cannabis impairment hasn't caught up to the policy need.
What This Study Doesn't Tell Us
This is a narrative review, not a systematic review, so the literature search may not be comprehensive. The legal landscape changes rapidly, and specific state-by-state details may already be outdated. The proposed framework is conceptual and hasn't been empirically tested in real workplace settings. The review focuses on U.S. law and may not apply to other jurisdictions.
Questions This Raises
- ?Can technology for real-time cannabis impairment testing (like oral fluid devices or cognitive testing apps) become reliable enough to replace urine testing in most workplaces?
- ?How are courts ruling on cannabis-related employment disputes in states with use protections?
- ?What's the actual rate of cannabis-impaired workplace accidents compared to alcohol-impaired ones?
Trust & Context
- Key Stat:
- Evidence Grade:
- This is a narrative review synthesizing existing research and legal frameworks. It provides practical policy guidance but doesn't present original data or follow a systematic review methodology.
- Study Age:
- Published in 2022, but cannabis laws change rapidly. Several more states have updated employment protections since publication.
- Original Title:
- Workplace Cannabis Policies: A Moving Target.
- Published In:
- Cannabis and cannabinoid research, 7(1), 16-23 (2022) — Cannabis and Cannabinoid Research is a peer-reviewed journal focused on the science and application of cannabis and cannabinoids.
- Authors:
- Hazle, Mia C, Hill, Kevin P(9), Westreich, Laurence M
- Database ID:
- RTHC-03905
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Read More on RethinkTHC
- employer-drug-test-thc-2026
- cannabis-security-clearances-federal-government
- thc-and-exercise-working-out-high
- thc-and-productivity-help-or-hurt
- thc-and-discipline-daily-use-willpower
- using-cannabis-at-work-risks-rights-science
- thc-competitive-gaming-esports-performance
- thc-creative-work-artists-musicians-writers
Cite This Study
https://rethinkthc.com/research/RTHC-03905APA
Hazle, Mia C; Hill, Kevin P; Westreich, Laurence M. (2022). Workplace Cannabis Policies: A Moving Target.. Cannabis and cannabinoid research, 7(1), 16-23. https://doi.org/10.1089/can.2020.0095
MLA
Hazle, Mia C, et al. "Workplace Cannabis Policies: A Moving Target.." Cannabis and cannabinoid research, 2022. https://doi.org/10.1089/can.2020.0095
RethinkTHC
RethinkTHC Research Database. "Workplace Cannabis Policies: A Moving Target." RTHC-03905. Retrieved from https://rethinkthc.com/research/hazle-2022-workplace-cannabis-policies-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.